Financial Contrast: Titan Medical (NASDAQ:TMDIF) vs. Biostage (OTCMKTS:BSTG)

Titan Medical (NASDAQ:TMDIF) and Biostage (OTCMKTS:BSTG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Profitability

This table compares Titan Medical and Biostage’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Biostage	N/A	N/A	-174.43%

Earnings & Valuation

This table compares Titan Medical and Biostage”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63 million	2.13	$6.95 million	$0.05	6.60
Biostage	N/A	N/A	-$6.07 million	($0.58)	-7.67

Titan Medical has higher revenue and earnings than Biostage. Biostage is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.0% of Titan Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 15.3% of Biostage shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Titan Medical and Biostage, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0	0	0	0	0.00
Biostage	0	0	1	0	3.00

Volatility and Risk

Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Biostage has a beta of -1.02, indicating that its stock price is 202% less volatile than the S&P 500.

Summary

Titan Medical beats Biostage on 7 of the 11 factors compared between the two stocks.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

About Biostage

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.